Literature DB >> 20551146

Strain-dependent variation in collateral circulatory function in mouse hindlimb.

Dan Chalothorn1, James E Faber.   

Abstract

The extent (density and diameter) of the native (preexisting) collateral circulation in healthy tissues and the capacity of collaterals to enlarge/remodel in obstructive arterial disease are important determinants of ischemic injury. Evidence suggests that these parameters vary widely from yet-to-be-identified genetic and environmental factors. Recently, a locus on chromosome 7 was linked to less recovery of perfusion after femoral artery ligation in BALB/c and A/J versus C57BL/6 mouse strains. Moreover, evidence suggested that BALB/c and A/J share an allele(s) at this locus that is different from C57BL/6 mice. Here we tested the hypothesis that differences in collateral extent and/or remodeling underlie these findings. Compared with C57BL/6, BALB/c and A/J strains have fewer native collaterals in hindlimb (also confirmed in brain)-associated with greater reduction in perfusion immediately after femoral ligation, slower recovery of perfusion, greater hindlimb use impairment, and worse ischemia. However, A/J also differed from BALB/c in a number of these parameters, including having more robust collateral remodeling. Analysis of A/J --> C57BL/6 chromosome substitution strains confirmed that a difference in an allele(s) on chromosome 7 conferred most, but not all, of the magnitude of the differences in collateral function. Additional studies of C57BL/6 x BALB/c F1 mice demonstrated that alleles of the C57BL/6 strain exert dominance for collateral traits. Finally, negative results were obtained from studies examining a previously identified candidate gene potentially responsible for these differences-Bcl2-associated athanogene-3. These findings emphasize the major contribution of genetic background to variation in the collateral circulation and its capacity to lessen ischemia in obstructive disease.

Entities:  

Mesh:

Year:  2010        PMID: 20551146      PMCID: PMC2929883          DOI: 10.1152/physiolgenomics.00070.2010

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  25 in total

Review 1.  Molecular chaperone targeting and regulation by BAG family proteins.

Authors:  S Takayama; J C Reed
Journal:  Nat Cell Biol       Date:  2001-10       Impact factor: 28.824

2.  Factors regulating arteriogenesis.

Authors:  Wolfgang Schaper; Dimitri Scholz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-04-03       Impact factor: 8.311

3.  BAG3 protein controls B-chronic lymphocytic leukaemia cell apoptosis.

Authors:  M F Romano; M Festa; G Pagliuca; R Lerose; R Bisogni; F Chiurazzi; G Storti; S Volpe; S Venuta; M C Turco; A Leone
Journal:  Cell Death Differ       Date:  2003-03       Impact factor: 15.828

Review 4.  Analysing complex genetic traits with chromosome substitution strains.

Authors:  J H Nadeau; J B Singer; A Matin; E S Lander
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

5.  Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis.

Authors:  Xuming Dai; James E Faber
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

6.  Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia.

Authors:  Dan Chalothorn; Hua Zhang; Jason A Clayton; Steven A Thomas; James E Faber
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-04-15       Impact factor: 4.733

7.  Strain-dependent vascular remodeling phenotypes in inbred mice.

Authors:  K J Harmon; L L Couper; V Lindner
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

8.  Genetic background influences therapeutic effectiveness of VEGF.

Authors:  Keiko Fukino; Masataka Sata; Yoshinori Seko; Yasunobu Hirata; Ryozo Nagai
Journal:  Biochem Biophys Res Commun       Date:  2003-10-10       Impact factor: 3.575

9.  Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice.

Authors:  Dimitri Scholz; Tibor Ziegelhoeffer; Armin Helisch; Shawn Wagner; Christian Friedrich; Thomas Podzuweit; Wolfgang Schaper
Journal:  J Mol Cell Cardiol       Date:  2002-07       Impact factor: 5.000

10.  Reactive astrocytes express bis, a bcl-2-binding protein, after transient forebrain ischemia.

Authors:  Mun-Yong Lee; Seong Yun Kim; Soon-Lim Shin; Yun-Sik Choi; Jung-Hee Lee; Yoshihide Tsujimoto; Jeong-Hwa Lee
Journal:  Exp Neurol       Date:  2002-06       Impact factor: 5.330

View more
  48 in total

1.  Genetic variation in retinal vascular patterning predicts variation in pial collateral extent and stroke severity.

Authors:  Pranay Prabhakar; Hua Zhang; De Chen; James E Faber
Journal:  Angiogenesis       Date:  2014-11-05       Impact factor: 9.596

2.  Exogenous thrombin delivery promotes collateral capillary arterialization and tissue reperfusion in the murine spinotrapezius muscle ischemia model.

Authors:  Anthony C Bruce; Shayn M Peirce
Journal:  Microcirculation       Date:  2012-02       Impact factor: 2.628

3.  Uncoupling angiogenesis and inflammation in peripheral artery disease with therapeutic peptide-loaded microgels.

Authors:  Angela L Zachman; Xintong Wang; Jason M Tucker-Schwartz; Sean T Fitzpatrick; Sue H Lee; Scott A Guelcher; Melissa C Skala; Hak-Joon Sung
Journal:  Biomaterials       Date:  2014-08-22       Impact factor: 12.479

4.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

5.  BAG3 (Bcl-2-Associated Athanogene-3) Coding Variant in Mice Determines Susceptibility to Ischemic Limb Muscle Myopathy by Directing Autophagy.

Authors:  Joseph M McClung; Timothy J McCord; Terence E Ryan; Cameron A Schmidt; Tom D Green; Kevin W Southerland; Jessica L Reinardy; Sarah B Mueller; Talaignair N Venkatraman; Christopher D Lascola; Sehoon Keum; Douglas A Marchuk; Espen E Spangenburg; Ayotunde Dokun; Brian H Annex; Christopher D Kontos
Journal:  Circulation       Date:  2017-04-25       Impact factor: 29.690

6.  Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice.

Authors:  Joseph M McClung; Timothy J McCord; Sehoon Keum; Soraya Johnson; Brian H Annex; Douglas A Marchuk; Christopher D Kontos
Journal:  Am J Pathol       Date:  2012-03-21       Impact factor: 4.307

Review 7.  Endothelial fluid shear stress sensing in vascular health and disease.

Authors:  Nicolas Baeyens; Chirosree Bandyopadhyay; Brian G Coon; Sanguk Yun; Martin A Schwartz
Journal:  J Clin Invest       Date:  2016-03-01       Impact factor: 14.808

8.  Short hairpin RNA gene silencing of prolyl hydroxylase-2 with a minicircle vector improves neovascularization of hindlimb ischemia.

Authors:  Maarten A Lijkwan; Alwine A Hellingman; Ernst J Bos; Koen E A van der Bogt; Mei Huang; Nigel G Kooreman; Margreet R de Vries; Hendrika A B Peters; Robert C Robbins; Jaap F Hamming; Paul H A Quax; Joseph C Wu
Journal:  Hum Gene Ther       Date:  2014-01-07       Impact factor: 5.695

9.  Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density.

Authors:  Joseph M McClung; Timothy J McCord; Kevin Southerland; Cameron A Schmidt; Michael E Padgett; Terence E Ryan; Christopher D Kontos
Journal:  J Vasc Surg       Date:  2015-08-05       Impact factor: 4.268

10.  De-novo collateral formation following acute myocardial infarction: Dependence on CCR2⁺ bone marrow cells.

Authors:  Hua Zhang; James E Faber
Journal:  J Mol Cell Cardiol       Date:  2015-08-04       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.